NDC 70771-1604

Solifenacin

Solifenacin

Solifenacin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Solifenacin Succinate.

Product ID70771-1604_205b6c54-6d0b-4c07-b4b8-7a95e9456282
NDC70771-1604
Product TypeHuman Prescription Drug
Proprietary NameSolifenacin
Generic NameSolifenacin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-02-10
Marketing CategoryANDA /
Application NumberANDA207721
Labeler NameZydus Lifesciences Limited
Substance NameSOLIFENACIN SUCCINATE
Active Ingredient Strength5 mg/1
Pharm ClassesCholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1604-3

30 TABLET, FILM COATED in 1 BOTTLE (70771-1604-3)
Marketing Start Date2022-02-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Solifenacin" or generic name "Solifenacin"

NDCBrand NameGeneric Name
68382-987SolifenacinSolifenacin
68382-988SolifenacinSolifenacin
70771-1604SolifenacinSolifenacin
70771-1605SolifenacinSolifenacin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.